Naveen Pemmaraju: Honored to be a featured MPN faculty speaker for upcoming Research Town Hall on Myelofibrosis
shared a post on LinkedIn:
“Honored to be a featured MPN faculty speaker for this upcoming MD Anderson Cancer Center Research Town Hall with focus on Myelofibrosis: The Next Frontier MPN – Stephen Oh, Prithviraj Bose, Naveen Pemmaraju, Lucia Masarova, Sanam Loghavi.”
Naveen Pemmaraju is a Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center (MDACC) and Executive Director of MDACC Network. He is also the Leukemia Hematology/Oncology Course Director.
His research work has been focused on improving outcomes and developing novel therapies for patients with rare, and ultra-rare, myeloid malignancies; including adolescents, young adults, and older adult patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), MPN and AML.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023